Newly presented data from a large, randomized Cardiothoracic Surgical Trials Network study show rate control and rhythm control to be equivalent for managing postoperative atrial fibrillation.
A multicenter trial finds high and unpredictable rates of recurrent leakage among mitral valve repair recipients, establishing replacement as the new standard of care for severe ischemic disease.
Robotic and catheter-based techniques promise to make mitral valve repair and replacement less invasive than ever. But how effective are they, and are robotic approaches ready to go mainstream?
The first randomized trial to assess use of ablation in patients with atrial fibrillation undergoing mitral valve surgery finds that ablation substantially improves heart rhythm vs. mitral valve surgery alone.